Cell death regulation by B-cell lymphoma protein

Bcl-2 (B Cell Lymphoma) protein is an anti-apoptotic member of Bcl-2 family, which is comprised of pro- and anti-apoptotic members. It regulates cellular proliferation and death by inter- and intra-family interactions. It has a potential to suppress apoptotic cell death under variety of stress conditions by modulating mitochondrial transmembrane potential. However, prevalence of constitutively activated Bcl-2 cellular activity is not always required in cells; a mechanism likely exists in cells, which controls its activity. When expression of Bcl-2 is unregulated, it generates lymphoma like, follicular B-cell lymphoma. This article reviews the structural and functional regulation of Bcl-2 activity at transcriptional, translational, domain, structural and post-translational level, which also accounts for the effects of its deletion and site-directed mutants in the regulation of cellular proliferation and differentiation in vitro and in vivo. This concisely reviewed information on Bcl-2 helps us to update our understanding of cell death and its modulation by Bcl-2 and its mutant’s interaction, which has gained therapeutic benefits in cell growth and proliferation, particularly for sensitive human hematopoietic stem cells.

[1]  C. Borner,et al.  Bcl-2 interrupts the ceramide-mediated pathway of cell death. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[2]  John Calvin Reed.  Bcl-2 and the regulation of programmed cell death , 1994, The Journal of cell biology.

[3]  D. Dunlop,et al.  Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphoma. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  M. Cleary,et al.  The p53-binding protein 53BP2 also interacts with Bc12 and impedes cell cycle progression at G2/M , 1996, Molecular and cellular biology.

[5]  John Calvin Reed.  Double identity for proteins of the Bcl-2 family , 1997, Nature.

[6]  Kazuhito Yamamoto,et al.  BCL-2 Is Phosphorylated and Inactivated by an ASK1/Jun N-Terminal Protein Kinase Pathway Normally Activated at G2/M , 1999, Molecular and Cellular Biology.

[7]  S. Fesik,et al.  Identification of a novel regulatory domain in Bcl‐xL and Bcl‐2 , 1997, The EMBO journal.

[8]  M. Cleary,et al.  The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation , 1989, Molecular and cellular biology.

[9]  M. Tomonaga,et al.  Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease. , 1997, Blood.

[10]  J C Reed,et al.  Mitochondria and apoptosis. , 1998, Science.

[11]  G. Lang,et al.  A transcriptional regulatory element in the coding sequence of the human Bcl‐2 gene , 2005, Immunology.

[12]  Ruedi Aebersold,et al.  Molecular characterization of mitochondrial apoptosis-inducing factor , 1999, Nature.

[13]  J. Martinou,et al.  The Bcl-2 protein family. , 2000, Experimental cell research.

[14]  P. Ruvolo.  Ceramide regulates cellular homeostasis via diverse stress signaling pathways , 2001, Leukemia.

[15]  John Calvin Reed,et al.  Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. , 1993, The Journal of biological chemistry.

[16]  A. Petros,et al.  Solution structure of the BHRF1 protein from Epstein-Barr virus, a homolog of human Bcl-2. , 2003, Journal of molecular biology.

[17]  A. Petros,et al.  Structural biology of the Bcl-2 family of proteins. , 2004, Biochimica et biophysica acta.

[18]  C. Borner,et al.  The protein bcl-2 alpha does not require membrane attachment, but two conserved domains to suppress apoptosis , 1994, The Journal of cell biology.

[19]  Y. Akao,et al.  Cyclic bcl-2 gene expression in human uterine endometrium during menstrual cycle , 1994, The Lancet.

[20]  John Calvin Reed,et al.  Identification of a p53-dependent negative response element in the bcl-2 gene. , 1994, Cancer research.

[21]  C. Croce,et al.  Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells. , 1998, Cancer research.

[22]  Matthew G. Vander Heiden,et al.  Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? , 1999, Nature Cell Biology.

[23]  S. Korsmeyer,et al.  Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. , 1990, Journal of immunology.

[24]  S. Fesik,et al.  Insights into Programmed Cell Death through Structural Biology , 2000, Cell.

[25]  M. Hengartner.  The biochemistry of apoptosis , 2000, Nature.

[26]  I. Weissman,et al.  Systemic Overexpression of BCL-2 in the Hematopoietic System Protects Transgenic Mice From the Consequences of Lethal Irradiation , 1998 .

[27]  I. Weissman,et al.  Self-renewal, differentiation or death: regulation and manipulation of hematopoietic stem cell fate. , 1999, Molecular medicine today.

[28]  J. Savill,et al.  What role does apoptosis play in progression of renal disease? , 1996, Current opinion in nephrology and hypertension.

[29]  L. Boise,et al.  Bcl-2 and Caspase Inhibition Cooperate to Inhibit Tumor Necrosis Factor-α-induced Cell Death in a Bcl-2 Cleavage-independent Fashion* , 1999, The Journal of Biological Chemistry.

[30]  A. Strasser,et al.  Bcl-2 Can Rescue T Lymphocyte Development in Interleukin-7 Receptor–Deficient Mice but Not in Mutant rag-1 −/− Mice , 1997, Cell.

[31]  I. Weissman,et al.  Enforced Expression of Bcl-2 in Monocytes Rescues Macrophages and Partially Reverses Osteopetrosis in op/op Mice , 1997, Cell.

[32]  John Calvin Reed,et al.  Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. , 1994, Oncogene.

[33]  S. Korsmeyer,et al.  BCL-2 family members and the mitochondria in apoptosis. , 1999, Genes & development.

[34]  F. Shibasaki,et al.  Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2 , 1997, Nature.

[35]  T. Fojo,et al.  Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. , 1997, Cancer research.

[36]  L. Boxer,et al.  Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis , 1996, Molecular and cellular biology.

[37]  S. Korsmeyer,et al.  Bcl-2 affects survival but not neuronal differentiation of PC12 cells , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[38]  D G Kirsch,et al.  Modulation of cell death by Bcl-XL through caspase interaction. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  W. May,et al.  Phosphorylation of Bcl2 and regulation of apoptosis , 2001, Leukemia.

[40]  K. Kinzler,et al.  Paradoxical inhibition of solid tumor cell growth by bcl2. , 1994, Cancer research.

[41]  Y. Otsuki,et al.  Identification of c-Jun as bcl-2 Transcription Factor in Human Uterine Endometrium , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[42]  M. Peter,et al.  Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor. , 1995, The EMBO journal.

[43]  G. Linette,et al.  Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[44]  C. Distelhorst,et al.  Bcl-2 on the endoplasmic reticulum: protecting the mitochondria from a distance , 2003, Journal of Cell Science.

[45]  John Calvin Reed,et al.  Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[46]  T. Ito,et al.  Ceramide Induces Bcl2 Dephosphorylation via a Mechanism Involving Mitochondrial PP2A* , 1999, The Journal of Biological Chemistry.

[47]  S. Frisch,et al.  Disruption of epithelial cell-matrix interactions induces apoptosis , 1994, The Journal of cell biology.

[48]  Patrick R. Griffin,et al.  Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis , 1995, Nature.

[49]  A. Wyllie,et al.  The genetic regulation of apoptosis. , 1995, Current opinion in genetics & development.

[50]  M. Lutter,et al.  Biochemical pathways of caspase activation during apoptosis. , 1999, Annual review of cell and developmental biology.

[51]  E. Cheng,et al.  Bax-independent inhibition of apoptosis by Bcl-XL , 1996, Nature.

[52]  N. Thornberry,et al.  Caspases: killer proteases. , 1997, Trends in biochemical sciences.

[53]  E. Cheng,et al.  Conversion of Bcl-2 to a Bax-like death effector by caspases. , 1997, Science.

[54]  J. L. Diaz,et al.  A Common Binding Site Mediates Heterodimerization and Homodimerization of Bcl-2 Family Members* , 1997, The Journal of Biological Chemistry.

[55]  T. Fojo,et al.  Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells , 1999, Leukemia.

[56]  John Calvin Reed,et al.  Bcl-2 Targets the Protein Kinase Raf-1 to Mitochondria , 1996, Cell.

[57]  F Gambale,et al.  Inhibition of Bax channel-forming activity by Bcl-2. , 1997, Science.

[58]  W. May,et al.  Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[59]  S. Capaccioli,et al.  A conserved AU‐rich element in the 3’ untranslated region of bcl‐2 mRNA is endowed with a destabilizing function that is involved in bcl‐2 down‐regulation during apoptosis , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[60]  Pascal Meier,et al.  Apoptosis in development , 2000, Nature.

[61]  C. Croce,et al.  Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. , 1996, Cancer research.

[62]  S. Korsmeyer,et al.  Solution Structure of the Proapoptotic Molecule BID A Structural Basis for Apoptotic Agonists and Antagonists , 1999, Cell.

[63]  T. Graf,et al.  NF‐M (chicken C/EBP beta) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line. , 1995, The EMBO journal.

[64]  Z. Oltvai,et al.  Bcl-2 functions in an antioxidant pathway to prevent apoptosis , 1993, Cell.

[65]  M. Mumby,et al.  Reversible Phosphorylation of Bcl2 following Interleukin 3 or Bryostatin 1 Is Mediated by Direct Interaction with Protein Phosphatase 2A* , 1998, The Journal of Biological Chemistry.

[66]  B. Palsson,et al.  Two new pseudopod morphologies displayed by the human hematopoietic KG1a progenitor cell line and by primary human CD34(+) cells. , 1998, Blood.

[67]  Y. Hannun,et al.  The sphingomyelin cycle and the second messenger function of ceramide. , 1994, The Journal of biological chemistry.

[68]  Y. Tsujimoto,et al.  BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[69]  A. Strasser,et al.  Localization of dynein light chains 1 and 2 and their pro-apoptotic ligands. , 2004, The Biochemical journal.

[70]  John Calvin Reed.  Mechanisms of Bcl-2 family protein function and dysfunction in health and disease. , 1996, Behring Institute Mitteilungen.

[71]  R. Meadows,et al.  X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death , 1996, Nature.

[72]  John Calvin Reed,et al.  Mechanisms of Transcriptional Activation of bcl-2Gene Expression by 17β-Estradiol in Breast Cancer Cells* , 1999, The Journal of Biological Chemistry.

[73]  Reed Jc.  Mechanisms of Bcl-2 family protein function and dysfunction in health and disease. , 1996 .

[74]  S. Korsmeyer,et al.  Alternative promoters and exons, somatic mutation and deregulation of the Bcl‐2‐Ig fusion gene in lymphoma. , 1988, The EMBO journal.

[75]  J. Sklar,et al.  Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation , 1986, Cell.

[76]  C. Borner,et al.  Dissection of functional domains in Bcl-2 alpha by site-directed mutagenesis. , 1994, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[77]  P. Marrack,et al.  The structure of a Bcl-xL/Bim fragment complex: implications for Bim function. , 2003, Immunity.

[78]  A. Pater,et al.  Cloning and characterization of the human BAG-1 gene promoter: upregulation by tumor-derived p53 mutants , 1999, Oncogene.

[79]  M C Peitsch,et al.  ProMod and Swiss-Model: Internet-based tools for automated comparative protein modelling. , 1996, Biochemical Society transactions.

[80]  R. Meadows,et al.  Structure of Bcl-xL-Bak Peptide Complex: Recognition Between Regulators of Apoptosis , 1997, Science.

[81]  C. Croce,et al.  Inactivation of Bcl-2 by phosphorylation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[82]  C. Weaver,et al.  Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[83]  A. Strasser,et al.  Apoptosis signaling. , 2000, Annual review of biochemistry.

[84]  Y. Tsujimoto,et al.  Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[85]  A. Petros,et al.  Solution structure of the antiapoptotic protein bcl-2 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[86]  David L. Vaux,et al.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.

[87]  S. Cory,et al.  The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.

[88]  John Calvin Reed,et al.  Heterodimerization-independent Functions of Cell Death Regulatory Proteins Bax and Bcl-2 in Yeast and Mammalian Cells* , 1997, The Journal of Biological Chemistry.

[89]  E. Cheng,et al.  A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[90]  R. Sharma,et al.  Structural conservation of residues in BH1 and BH2 domains of Bcl‐2 family proteins , 2005, FEBS letters.

[91]  M. Gossen,et al.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[92]  L. Neckers,et al.  Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. , 1996, Cancer research.